Immune Design Raises $32 Million
Immune Design Corp., a Seattle-based, has raised $32 million in Series B funding. ProQuest Investments led the round, and was joined by return backers Column Group, Versant Ventures and Alta Partners.
27 July 2010•2 mins read
